Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Efficacy and Safety of KN026 Combination Chemotherapy ± KN046 in HER2-Positive Advanced Colorectal Cancer and Biliary Tract Cancer as First-Line Treatment: a Phase Ⅱ Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05985707
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:37.438750+00:00
Published At
2023-08-21T00:00:00+00:00
Record Updated At
2023-08-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["HER2-positive Colorectal Cancer", "HER2-positive Biliary Tract Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-21"
protocolSection.identificationModule.nctId
"NCT05985707"
protocolSection.identificationModule.officialTitle
"The Efficacy and Safety of KN026 Combination Chemotherapy \u00b1 KN046 in HER2-Positive Advanced Colorectal Cancer and Biliary Tract Cancer as First-Line Treatment\uff1a a Phase \u2161 Study"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • HER2-positive Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • HER2-positive Biliary Tract Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.